ref_name,rx_name,dosage,host,infection_name,variant_name,patient,sampling,num_patients,num_patients_with_mut,section,note,date_added
Copin21,None,None,Human,Unknown,S:427N,Hospitalized,None,90,4,Figure 4B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,low,Human,Unknown,S:477N,Hospitalized,None,88,3,Figure 4B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,low,Human,Unknown,S:501T,Hospitalized,None,88,4,Figure 4B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,low,Human,Unknown,S:537R,Hospitalized,None,88,2,Figure 4B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,high,Human,Unknown,S:477N,Hospitalized,None,109,5,Figure 4B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,high,Human,Unknown,S:501N,Hospitalized,None,109,3,Figure 4B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,None,None,Human,Unknown,S:477N,Nonhospitalized,None,216,6,Figure 6B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,None,None,Human,Unknown,S:520S,Nonhospitalized,None,216,3,Figure 6B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,low,Human,Unknown,S:477N,Nonhospitalized,None,248,5,Figure 6B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,low,Human,Unknown,S:446V,Nonhospitalized,None,248,4,Figure 6B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,Casirivimab+Imdevimab,high,Human,Unknown,S:494P,Nonhospitalized,None,212,3,Figure 6B,>=2 samples from >=1 patient (uncertain how many samples sequenced per person),2021-03-13
Copin21,None,None,Hamster,WA1,NoMut,None,None,10,0,Figure 3,RBD/Prevention,2021-03-13
Copin21,Casirivimab+Imdevimab,None,Hamster,WA1,NoMut,None,None,10,0,Figure 3,RBD/Prevention,2021-03-13
Copin21,None,None,Hamster,WA1,NoMut,None,None,10,0,Figure 3,RBD/Treatment,2021-03-13
Copin21,Casirivimab+Imdevimab,None,Hamster,WA1,NoMut,None,None,10,0,Figure 3,RBD/Treatment,2021-03-13
Copin21,Casirivimab,None,Hamster,WA1,S:486S,None,None,10,3,Figure 3,RBD/Prevention,2021-03-13
Copin21,Casirivimab,None,Hamster,WA1,S:455W,None,None,10,1,Figure 3,RBD/Prevention,2021-03-13
Copin21,Casirivimab,None,Hamster,WA1,NoMut,None,None,10,0,Figure 3,RBD/Treatment,2021-03-13
Copin21,Imdevimab,None,Hamster,WA1,S:384L,None,None,10,1,Figure 3,RBD/Prevention,2021-03-13
Copin21,Imdevimab,None,Hamster,WA1,S:446D,None,None,10,7,Figure 3,RBD/Prevention,2021-03-13
Copin21,Imdevimab,None,Hamster,WA1,S:455W,None,None,10,1,Figure 3,RBD/Prevention,2021-03-13
Copin21,Imdevimab,None,Hamster,WA1,S:444T,None,None,10,5,Figure 3,RBD/Treatment,2021-03-13
Copin21,Imdevimab,None,Hamster,WA1,S:446S,None,None,10,1,Figure 3,RBD/Treatment,2021-03-13
